Advertisement

Reactions Weekly

, Volume 1743, Issue 1, pp 82–82 | Cite as

Doxorubicin/trametinib

Hand-Foot syndrome and rash: case report
Case report
  • 13 Downloads

Reference

  1. Champer M, et al. Response to trametinib in recurrent low-grade serous ovarian cancer with NRAS mutation: A case report. Gynecologic Oncology Reports 28: 26-28, May 2019. Available from: URL: http://doi.org/10.1016/j.gore.2019.01.007 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations